Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles
Douglas W. Brown,Ping Wee,Prakash Bhandari,Amirali Bukhari,Liliya Grin,Hector Vega,Maryam Hejazi,Deborah Sosnowski,Jailal Ablack,Eileen K. Clancy,Desmond Pink,Jitendra Kumar,Maria Paola Solis Ares,Suellen Lamb,Rodrigo Quevedo,Bijal Rawal,Fahed Elian,Natasha Rana,Luis Morales,Natasha Govindasamy,Brendan Todd,Angela Delmage,Somnath Gupta,Nichole McMullen,Duncan MacKenzie,Perrin H. Beatty,Henry Garcia,Manoj Parmar,Jennifer Gyoba,Chandra McAllister,Matthew Scholz,Roy Duncan,Arun Raturi,John D. Lewis
DOI: https://doi.org/10.1016/j.cell.2024.07.023
IF: 64.5
2024-09-20
Cell
Abstract:Current genetic medicines are limited by tolerability, scalability, and immunogenicity issues. Utilizing components from viral and non-viral delivery platforms, we developed a lipid-based delivery vehicle formulated with a chimeric fusion protein that delivers nucleic acid cargo inside cells effectively and with broad distribution and low immunogenicity. This proteolipid vehicle platform is suitable for safe and effective repeat dosing of DNA and/or RNA in vivo.
cell biology,biochemistry & molecular biology